Figure 1
From: MALP-2 pre-treatment modulates systemic inflammation in hemorrhagic shock
Study design of experiment. Animals were subjected into three treatment groups (n=6). Group HS (Hemorrhagic Shock) received 100 μl (intraperitoneal (i.p.) injection of phosphate buffered saline (PBS) 90 minutes after induction of HS, Group MALP T (Treatment) received an i.p. injection of MALP-2 (4 μg/kg BW) dissolved in 100 μl of PBS after the induction of HS, and Group MALP PT (Pre-Treatment) received an i.p. pre-treatment of MALP-2 twelve hours prior the initiation of HS. Mice were sacrificed 6 hours following HS.